Visceral motion

Visceral motion refers to the involuntary movement of internal organs within the thoracic and abdominal cavities, primarily driven by physiological processes such as respiration, cardiac activity, and gastrointestinal peristalsis (IJROBP, 2006). It is a macroscopic physiological phenomenon rather than a specific molecular target, receptor, or enzyme. In clinical medicine, managing visceral motion is critical for high-resolution diagnostic imaging and the precise delivery of radiation therapy, where motion can cause significant artifacts or lead to geographical misses of tumors (ResearchGate, 2025). Pharmacological control of this motion is typically achieved by targeting receptors within the autonomic or enteric nervous systems to either suppress movement during medical procedures or restore normal motility in disease states like gastroparesis or irritable bowel syndrome (Cleveland Clinic, 2024). Consequently, while 'visceral motion' is a focus of therapeutic intervention and clinical planning, it does not represent a single protein or gene entity.

Other names

Organ motionInternal organ motionPhysiological motionIntrafraction motionPeristaltic movement

Pharmacological agents influence visceral motion by modulating signaling in the autonomic and enteric nervous systems, typically acting as agonists or antagonists at muscarinic acetylcholine receptors, dopamine D2 receptors, or serotonin (5-HT4) receptors to regulate smooth muscle contraction (StatPearls, 2023; Cleveland Clinic, 2024).